We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Having SARS-CoV-2 Antibodies Appears To Protect Well Against Reinfection

News   Feb 25, 2021 | Original story from National Institutes of Health

 
Having SARS-CoV-2 Antibodies Appears To Protect Well Against Reinfection

Credit: Shaun F/ Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine

News

The Danish Health Authority has decided to continue its vaccination programme against COVID-19 without the vaccine from AstraZeneca.

READ MORE

The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine

News

The United States Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) have recommended pausing the use of the Johnson & Johnson (Janssen) COVID-19 vaccine. In addition, Janssen has declared that it will "proactively delay" the rollout of the vaccine in Europe.

READ MORE

Targeting the Tumor Environment in Pregnancy-Associated Breast Cancer

News

A new study has uncovered how breast cancer cells that develop during or after pregnancy alter their environment to allow the formation of more aggressive tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE